CBOE Volatility (VIX) - Conventional wisdom on The Street states that a bear market is usually paired with a spike in the VIX.
Historically, that relationship has been pretty solid, but this year has investors scratching their heads.
Despite carnage across the board, the fear gauge has been more subdued than expected.
That trend was bucked Friday as the VIX shot upwards. TBD if it will continue.
At the end of the session, VIX was up 10.02%.
Evaxion Biotech ($EVAX) - Skin cancer is the most common form of cancer in the U.S., and melanoma is the most deadly form.
Evaxion is a Danish company working on personalized treatments for melanoma, and it just enrolled its first patient in a new clinical trial, marking a critical milestone.
If the trial shows promising results, this tiny player could catapult itself into a multi-billion dollar giant in the huge market for skin cancer treatments globally.
$EVAX was up 20.99% by the end of the day.